Jérémie Joffre

Jérémie Joffre

Auto-generated profile, based on publicly available information

Jérémie Joffre

Intensive Care Unit, Saint-Antoine University Hospital, APHP, Sorbonne University, Paris, France

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2022 in Annals of Intensive Care
Verified
Journal Article
Open access
PDF file
GVGuillaume Voiriot
Guillaume Voiriot
MOMehdi Oualha
Mehdi Oualha
APAlexandre Pierre
Alexandre Pierre
CSCharlotte Salmon-Gandonnière
Charlotte Salmon-Gandonnière
AGAlexandre Gaudet
Alexandre Gaudet
JJJérémie Joffre
Jérémie Joffre
Post‐intensive care syndrome (PICS) encompasses physical, cognition, and mental impairments persisting after intensive care unit (ICU) discharge. Ultimately it significantly impacts the long‐term prognosis, both in functional outcomes and survival. Thus, survivors often develop permanent disabilities, consume a lot of healthcare resources, and may experience prolonged suffering. This review aims to present the multiple facets of the PICS, decipher its underlying mechanisms, and highlight future research directions. This review abridges the translational data underlying the multiple facets of chronic critical illness (CCI) and PICS. We focus first on ICU-acquired weakness, a syndrome characterized by impaired contractility, muscle wasting, and persisting muscle atrophy during the recovery phase, which involves anabolic resistance, impaired capacity of regeneration, mitochondrial dysfunction, and abnormalities in calcium homeostasis. Second, we discuss the clinical relevance of post-ICU cognitive impairment and neuropsychological disability, its association with delirium during the ICU stay, and the putative role of low-grade long-lasting inflammation. Third, we describe the profound and persistent qualitative and quantitative alteration of the innate and adaptive response. Fourth, we discuss the biological mechanisms of the progression from acute to chronic kidney injury, opening the field for renoprotective strategies. Fifth, we report long-lasting pulmonary consequences of ARDS and prolonged mechanical ventilation. Finally, we discuss several specificities in children, including the influence of the child’s pre-ICU condition, development, and maturation. Recent understandings of the biological substratum of the PICS’ distinct features highlight the need to rethink our patient trajectories in the long term. A better knowledge of this syndrome and precipitating factors is necessary to develop protocols and strategies to alleviate the CCI and PICS and ultimately improve patient recovery.

15 June 2020 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JJJérémie Joffre
Jérémie Joffre
CYChe-Chung Yeh
Che-Chung Yeh
EWErika Wong
Erika Wong
MTMayuri Thete
Mayuri Thete
FXFengyun Xu
Fengyun Xu
JHJudith Hellman
Judith Hellman
Cannabis sativa and its principal components, Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol, are increasingly being used to treat a variety of medical problems, including inflammatory conditions. Although studies suggest that the endocannabinoid system has immunomodulatory properties, there remains a paucity of information on the effects of cannabinoids on immunity and on outcomes of infection and injury. We investigated the effects and mechanism(s) of action of cannabinoid receptor agonists, including Δ9-THC, on inflammation and organ injury in endotoxemic mice. Administration of Δ9-THC caused a dramatic early upregulation of plasma IL-10 levels, reduced plasma IL-6 and CCL-2 levels, led to better clinical status, and attenuated organ injury in endotoxemic mice. The anti-inflammatory effects of Δ9-THC in endotoxemic mice were reversed by a cannabinoid receptor type 1 (CB1R) inverse agonist (SR141716), and by clodronate-induced myeloid-cell depletion, but not by genetic invalidation or blockade of other putative Δ9-THC receptors, including cannabinoid receptor type 2, TRPV1, GPR18, GPR55, and GPR119. Although Δ9-THC administration reduced the activation of several spleen immune cell subsets, the anti-inflammatory effects of Δ9-THC were preserved in splenectomized endotoxemic mice. Finally, using IL-10–GFP reporter mice, we showed that blood monocytic myeloid-derived suppressive cells mediate the Δ9-THC–induced early rise in circulating IL-10. These results indicate that Δ9-THC potently induces IL-10, while reducing proinflammatory cytokines, chemokines, and related organ injury in endotoxemic mice via the activation of CB1R. These data have implications for acute and chronic conditions that are driven by dysregulated inflammation, such as sepsis, and raise the possibility that CB1R-signaling may constitute a novel target for inflammatory disorders. Key Points Δ9-THC increases IL-10 and reduces IL-6 and CCL2 in endotoxemic mice via CB1R. Δ9-THC decreases lung inflammation and organ injury in endotoxemic mice. Monocytic-MDSCs mediate Δ9-THC–induced IL-10 upregulation in endotoxemic mice.

29 August 2023 in Chest
Verified
Journal Article
Closed access
VMVinca Montméat
Vinca Montméat
VBVincent Bonny
Vincent Bonny
TUTomas Urbina
Tomas Urbina
LMLouai Missri
Louai Missri
JBJean-Luc Baudel
Jean-Luc Baudel
JJJérémie Joffre
Jérémie Joffre

1 September 2023 in Minerva Anestesiologica
Verified
Journal Article
Closed access
AVAntoine Villa
Antoine Villa
WBWulfran Bougouin
Wulfran Bougouin
TUTomas Urbina
Tomas Urbina
VBVincent Bonny
Vincent Bonny
PGPaul Gabarre
Paul Gabarre
JJJérémie Joffre
Jérémie Joffre
Article: Impact of immunosuppressive regimen on ICU acquired pneumonia in critically ill COVID-19 - Minerva Anestesiologica 2023 May 11 - Minerva Medica - Journals

1 April 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
JJJeremie Joffre
Jeremie Joffre
Letter for the article Common Variables That Influence Sepsis Mortality in Mice

30 September 2025 in Critical Care
Verified
Journal Article
Open access
PDF file
JDJean-Baptiste Destival
Jean-Baptiste Destival
TUTomas Urbina
Tomas Urbina
WBWulfran Bougouin
Wulfran Bougouin
JLJudith Leblanc
Judith Leblanc
SSSacha Seksik
Sacha Seksik
DAdjillali Annane
djillali Annane
Autoimmune hemolytic anemia (AIHA) is a rare but potentially life-threatening condition requiring intensive care unit (ICU) admission in severe cases. While corticosteroids and immunosuppressants are standard treatments, their delayed efficacy limits their utility in critical settings requiring rapid hemolysis control. Plasma exchange (PlEx) may offer a rapid intervention, but its effectiveness in severe AIHA remains uncertain. This study aims to assess the clinical characteristics, outcomes, and the potential benefit of PlEx in ICU cases with severe AIHA. We conducted a multicenter retrospective cohort study including patients with severe AIHA admitted to 15 ICUs within the Assistance Publique–Hôpitaux de Paris (AP-HP) network between 2017 and 2024. Clinical, biological, and therapeutic data were collected. A multivariate logistic regression model, an analysis adjusted on a propensity score (PS) and on inverse probability of treatment weighting (IPTW) were used to identify predictors of in-ICU mortality and evaluate the association between PlEx and in-ICU mortality. One hundred forty-eight ICU stays involving severe AIHA hemolytic crises were analyzed. The median age at ICU admission was 61 {48–71} years, with a balanced sex ratio (51% male). Admission median hemoglobin was 5.2 g/dL {4.2–7.2} and in-ICU mortality was 17.6%. Risk factors for in-ICU mortality included age > 60 years, renal replacement therapy, mechanical ventilation, and high-dose intravenous methylprednisolone (HDIM). Therefore, ICU mortality was mainly driven by organ dysfunction rather than anemia severity. Standard corticosteroid therapy (1–2 mg/kg) (OR:0.19 [0.03–0.94], P = 0.05) and PlEx (OR:0.04 [0.004–0.4], P = 0.008) were associated with improved survival. The association between PlEx and outcome persisted after PS (OR: 0.04 [0.001–0.39]; P = 0.012) and IPTW (OR: 0.13 [0.02–0.55]; P = 0.011) adjustment. In this large ICU cohort, severe AIHA was associated with high mortality, driven by organ failure rather than anemia severity. PlEx are associated with survival, suggesting its potential role as a bridge to immunosuppressive therapy in selected cases. Prospective studies are needed to confirm these findings.